 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
| «12...20212223242526272829303132 |
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
NOOOOOOO!!!!, queremos la vacuna Rusa Sputnik V por favor!!!!, las otras no @lopezobrador_ @JaimeRdzNL @DrManueldelaO (Twitter) - Oct 13, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Es una lástima que no haya planes para la sputnik v (Twitter) - Oct 13, 2020
- ||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Adverse events: I am sure the Govt. and politicians want people to die, that is why they have stopped this trial of Sputnik V Vaccine ....its normal to have side effects.... govt wants people to suffer and die, I totally blame them for this chaos. #peopleslivesmatter 🙏#VaccinesSaveLives (Twitter) - Oct 8, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Sputnik vaccine 13 euros a shot already available! (Twitter) - Oct 7, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
For those who are still sceptical about Sputnik V vaccine. Scientists say "It is excellent platform". https://t.co/WEoeTpaE3Q (Twitter) - Oct 6, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Doubt that Sir. Various vaccines currently in phase III trials & it's better not to try shortcuts like the Russians did with their 'Sputnik V'. Just following news since January via: https://t.co/lcXK0jy4bg , better ask @CEPIvaccines or @mvankerkhove for a very informed opinion (Twitter) - Oct 4, 2020
- |||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
FDA event: Rajdeep kept harping about Sputnik vaccine (which he mispronounced) which is neither peer reviewed or approved by any agency of repute like the FDA. Not a word about Pfizer which has 4 vaccines under development, 2 at advanced stage. Not one about J&J who has a single dose vacc. (Twitter) - Oct 4, 2020
- |||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Clinical: Russia’s Sputnik-V vaccine against coronavirus has been heavily criticised in the West, but are their doubts justified? RT Documentary’s Konstantin Rozhkov gets down to the nitty gritty of the vaccine as he becomes a test subject in Phase 3 trial https://t.co/eokjhnJklZ (Twitter) - Oct 2, 2020
- |||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
#SputnikVLlegaAVenezuela #SistemaPetroInmobiliario #QuédateEnCasa #CombatientesDigitales #ModoActivo @Pontifex_es @DrTedros @CICR_es @opsoms @ONU_es @UNIONEUROPEA @acfimanve @inafinogenova @VP @MedicosUnidosVe @juliocastrom @DouglasLeonNate VENEZUELA Y RUSIA VENCIENDO COVID19 (Twitter) - Oct 2, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Enrollment open: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus (clinicaltrials.gov) - Oct 1, 2020
P3, N=100, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Not yet recruiting --> Recruiting
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
@SputnikV ? (Twitter) - Sep 29, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Both the panelists were as diplomatic as possible about #SputnikV . That’s what happens when a country is not transparent it’s bound to create trust deficiencies amongst fellow nations, this holds good for China too.@sardesairajdeep @doctorsoumya @mvankerkhove (Twitter) - Sep 28, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
New P3 trial: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus (clinicaltrials.gov) - Sep 25, 2020
P3, N=100, Not yet recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Trial completion date, Trial primary completion date: RESIST: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (clinicaltrials.gov) - Sep 25, 2020
P3, N=40000, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Not yet recruiting --> Recruiting Trial completion date: Dec 2022 --> May 2021 | Trial primary completion date: Dec 2022 --> May 2021
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
🩺@BobDjavan von der Wiener Privatklinik: 💬 Sputnik-V hat möglicherweise Potential, das COVID-Virus in den Griff zu bekommen. Ich halte es zumindest für eine Chance. Kronen Zeitung, Ausgabe vom 20.09.2020 (Twitter) - Sep 22, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: exec https://t.co/xDFVVBkKbA (Twitter) - Sep 22, 2020
- ||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Now do Sweden. Also India is probably already negotiating with Russia for several million doses of Sputnik V. The Indian equity markets have been grinding higher as they will make the vaccine mandatory and get back to normal much quicker. Disclosure: I’m long Indian Shares. (Twitter) - Sep 13, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Señor @DrGiammattei @easturia me imagino que con la reapertura del país también se pensó en la adquisición del la vacuna Sputnik V (Twitter) - Sep 11, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Enrollment open: RESIST: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (clinicaltrials.gov) - Sep 11, 2020
P3, N=40000, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Trial completion date: Dec 2022 --> May 2021 | Trial primary completion date: Dec 2022 --> May 2021 Not yet recruiting --> Recruiting
- ||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
NY Times take on the Russian COVID vaccine data just published in Lancet. Vaccine appropriately named "Sputnik V". I am not signing up for it yet. Russians Publish Early Coronavirus Vaccine Results https://t.co/NogF4I24Pp via @doximity (Twitter) - Sep 10, 2020
- |||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Preclinical: "La vacuna rusa del Covid-19 Sputnik V demuestra eficacia y seguridad y NO genera reacciones adversas, según este estudio publicado en The Lancet" además tiene 2 vectores, mientras que otras sólo tienen uno de ellos y otras con vectores animales (del mono) ¿Cuál aconseja Doctor? (Twitter) - Sep 9, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Sputnik V already available and recognised by the Lancet (Twitter) - Sep 7, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
@DrTedros Has the @WHO received data about a Russian Vaccine called #SputnikV from The Kremlin? (Twitter) - Sep 6, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
I want Sputnik-V ... I trust in the @KremlinRussia_E (Twitter) - Sep 4, 2020
- ||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Russians Publish Early Coronavirus Vaccine Results The first batch of public data from the “Sputnik V” vaccine showed that it was safe and produced an immune response. No one knows yet whether it prevents coronavirus infections https://t.co/iqcTiK4gaW (Twitter) - Sep 4, 2020
- || Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
I respect Russian scientists. But that name, that name. I remember Sputnik. We were scared to death when it was launched. But as names go, is "Sputnik V" any worse than "Operation Fast Forward"? Chest thumping on both sides. (Twitter) - Sep 4, 2020
- ||| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
P1 data: 1/3 Thread: I was glad to see the Russians publish their phase 1 data, previously I was critical for their lack of transparency after their public declarations following licensure of "Sputnik V" or whatever the heck they were calling it. Some positives and negatives: (Twitter) - Sep 4, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Pharmaceutical industry Sputnik V (Twitter) - Sep 2, 2020
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
New P3 trial: RESIST: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (clinicaltrials.gov) - Aug 28, 2020
P3, N=40000, Not yet recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Trial completion: An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19 (clinicaltrials.gov) - Aug 11, 2020
P1/2, N=38, Completed, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Trial completion: An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 (clinicaltrials.gov) - Aug 11, 2020
P1/2, N=38, Completed, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Enrollment closed: An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19 (clinicaltrials.gov) - Jul 6, 2020
P1/2, N=38, Active, not recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
Enrollment closed: An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 (clinicaltrials.gov) - Jul 6, 2020
P1/2, N=38, Active, not recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
New P1/2 trial: An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19 (clinicaltrials.gov) - Jun 18, 2020
P1/2, N=38, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- | Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute
New P1/2 trial: An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 (clinicaltrials.gov) - Jun 18, 2020
P1/2, N=38, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- | GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
New P1/2 trial: A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) - Jul 29, 2019
P1/2, N=50, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- | GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
Trial completion, P1 data: A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) - Dec 28, 2017
P1, N=36, Completed, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
Enrollment closed, P1 data: A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) - Nov 29, 2017
P1, N=36, Active, not recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
Enrollment open, P1 data: A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) - Jun 15, 2017
P1, N=36, Recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
New P1 trial, P1 data: A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) - May 3, 2017
P1, N=36, Not yet recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation